Q&A—how to apply ctDNA in medical management—differing approaches by the panel reflects lack of existing data on whether ready for prime time and if it shld lead to a change in care compared to using clinical/path alone. #blcsm #SUO24
Reposted from
David Y.T. Chen
Day 1 #SUO24
Starting the afternoon discussing #bladdercancer therapy for adjuvant and in advanced disease.
➡️How far we’ve come beyond having largely just cystectomy. #blcsm
Starting the afternoon discussing #bladdercancer therapy for adjuvant and in advanced disease.
➡️How far we’ve come beyond having largely just cystectomy. #blcsm
Comments